MeSH tree: C10.668.829.800.750
Chinese scientists reveal the feasibility, tolerability, and efficacy of BCMA-CD19 bispecific CAR T-cells for treating chronic inflammatory demyelinating polyneuropathy (CIDP) and highlight the potential of CAR-T cell therapy ...
Jun 20, 2024
0
51
Barré syndrome (GBS) is a rare immune-mediated peripheral neuropathy that can cause permanent disability and even death and be quite severe to manage. In this acute disorder, which typically triggers after a respiratory or ...
Apr 11, 2024
0
37
Influenza is a common respiratory infection. Although most cases are relatively mild, flu can cause more severe illness in young children and older people.
Apr 3, 2024
0
51
A recent study led by researchers at University Hospitals (UH) Connor Whole Health and collaborators at Duke University Medical School examined whether chiropractic spinal manipulation could lead to an increased risk of cauda ...
Mar 26, 2024
0
65
Vaccines that protect against severe illness, death and lingering long COVID symptoms from a coronavirus infection were linked to small increases in neurological, blood, and heart-related conditions in the largest global ...
Feb 19, 2024
0
346
Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the October 18, 2023, online issue ...
Oct 18, 2023
0
96
The first vaccine for respiratory syncytial virus (RSV) has been approved by the U.S. Food and Drug Administration for use in seniors aged 60 and older.
May 3, 2023
0
45
In a tight vote, U.S. Food and Drug Administration advisors on Tuesday recommended the approval of an RSV vaccine that could be used in Americans ages 60 and up.
Mar 1, 2023
0
46
There is no evidence that the COVID-19 vaccination increases the incidence of Guillain-Barré syndrome, a rare neurological disorder in which the body's immune system attacks the nerves, according to a Rutgers-led study.
Oct 4, 2022
0
80
South Africa's medicines regulatory authority says it has recorded two fatal cases of the rare Guillain-Barre syndrome in people who had received a Johnson & Johnson COVID jab.
Sep 13, 2022
0
217
